These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23436584)

  • 61. Performance of 18F-FDG PET/contrast-enhanced CT in the staging of squamous cell carcinoma of the oral cavity and oropharynx.
    Krabbe CA; Balink H; Roodenburg JL; Dol J; de Visscher JG
    Int J Oral Maxillofac Surg; 2011 Nov; 40(11):1263-70. PubMed ID: 21824748
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Predictive markers, including total lesion glycolysis, for the response of lymph node(s) metastasis from head and neck squamous cell carcinoma treated by chemoradiotherapy.
    Nishimura G; Komatsu M; Hata M; Yabuki K; Taguchi T; Takahashi M; Shiono O; Sano D; Arai Y; Takahashi H; Chiba Y; Oridate N
    Int J Clin Oncol; 2016 Apr; 21(2):224-230. PubMed ID: 26272533
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pitfalls of post-treatment PET after de-intensified chemoradiotherapy for HPV-associated oropharynx cancer: Secondary analysis of a phase 2 trial.
    Wang K; Wong TZ; Amdur RJ; Mendenhall WM; Sheets NC; Green R; Thorp BD; Patel SN; Hackman TG; Zanation AM; Weissler MC; Chera BS
    Oral Oncol; 2018 Mar; 78():108-113. PubMed ID: 29496037
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for Locoregional advanced head and neck cancer.
    Ong SC; Schöder H; Lee NY; Patel SG; Carlson D; Fury M; Pfister DG; Shah JP; Larson SM; Kraus DH
    J Nucl Med; 2008 Apr; 49(4):532-40. PubMed ID: 18344440
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Strategy of Using Intratreatment Hypoxia Imaging to Selectively and Safely Guide Radiation Dose De-escalation Concurrent With Chemotherapy for Locoregionally Advanced Human Papillomavirus-Related Oropharyngeal Carcinoma.
    Lee N; Schoder H; Beattie B; Lanning R; Riaz N; McBride S; Katabi N; Li D; Yarusi B; Chan S; Mitrani L; Zhang Z; Pfister DG; Sherman E; Baxi S; Boyle J; Morris LG; Ganly I; Wong R; Humm J
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):9-17. PubMed ID: 27511842
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Can "early" and "late"18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy?
    Castaldi P; Rufini V; Bussu F; Miccichè F; Dinapoli N; Autorino R; Lago M; De Corso E; Almadori G; Galli J; Paludetti G; Giordano A; Valentini V
    Radiother Oncol; 2012 Apr; 103(1):63-8. PubMed ID: 22459579
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prognostic value of pretreatment 18F-fluorodeoxyglucose positron emission tomography/CT volume-based parameters in patients with oropharyngeal squamous cell carcinoma with known p16 and p53 status.
    Kikuchi M; Koyasu S; Shinohara S; Usami Y; Imai Y; Hino M; Itoh K; Tona R; Kanazawa Y; Kishimoto I; Harada H; Naito Y
    Head Neck; 2015 Oct; 37(10):1524-31. PubMed ID: 24890445
    [TBL] [Abstract][Full Text] [Related]  

  • 68. PET-CT staging of the neck in cancers of the oropharynx: patterns of regional and retropharyngeal nodal metastasis.
    Tauzin M; Rabalais A; Hagan JL; Wood CG; Ferris RL; Walvekar RR
    World J Surg Oncol; 2010 Aug; 8():70. PubMed ID: 20712875
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The role of neck dissection in the setting of chemoradiation therapy for head and neck squamous cell carcinoma with advanced neck disease.
    Hamoir M; Ferlito A; Schmitz S; Hanin FX; Thariat J; Weynand B; Machiels JP; Grégoire V; Robbins KT; Silver CE; Strojan P; Rinaldo A; Corry J; Takes RP
    Oral Oncol; 2012 Mar; 48(3):203-10. PubMed ID: 22104248
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Use of 18F-Fludeoxyglucose-Positron Emission Tomography/Computed Tomography for Patient Management and Outcome in Oropharyngeal Squamous Cell Carcinoma: A Review.
    Taghipour M; Sheikhbahaei S; Marashdeh W; Solnes L; Kiess A; Subramaniam RM
    JAMA Otolaryngol Head Neck Surg; 2016 Jan; 142(1):79-85. PubMed ID: 26583955
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Radiographic Imaging Does Not Reliably Predict Macroscopic Extranodal Extension in Human Papilloma Virus-Associated Oropharyngeal Cancer.
    Patel MR; Hudgins PA; Beitler JJ; Magliocca KR; Griffith CC; Liu Y; Bougnon K; El-Deiry M; Saba NF; Aiken AH
    ORL J Otorhinolaryngol Relat Spec; 2018; 80(2):85-95. PubMed ID: 29969771
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prognostic significance of tumor response as assessed by sequential 18F-fluorodeoxyglucose-positron emission tomography/computed tomography during concurrent chemoradiation therapy for cervical cancer.
    Oh D; Lee JE; Huh SJ; Park W; Nam H; Choi JY; Kim BT
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):549-54. PubMed ID: 24074928
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Management of the "violated neck" in the era of chemoradiation.
    Loyo M; Johnson JT; Westra WH; Chiosea SI; Gourin CG
    Laryngoscope; 2011 Nov; 121(11):2349-58. PubMed ID: 21993776
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Occult contralateral nodal disease in oropharyngeal squamous cell carcinoma patients undergoing primary TORS with bilateral neck dissection.
    McMullen CP; Garneau J; Weimar E; Ali S; Farinhas JM; Yu E; Som PM; Sarta C; Goldstein DP; Su S; Xu W; Smith RV; Miles B; de Almeida JR
    Oral Oncol; 2019 Jun; 93():96-100. PubMed ID: 31109703
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Interaction of quantitative (18)F-FDG-PET-CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma.
    Schouten CS; Hakim S; Boellaard R; Bloemena E; Doornaert PA; Witte BI; Braakhuis BJ; Brakenhoff RH; Leemans CR; Hoekstra OS; de Bree R
    Head Neck; 2016 Apr; 38(4):529-35. PubMed ID: 25352335
    [TBL] [Abstract][Full Text] [Related]  

  • 76. p16 status and interval neck dissection findings after a 'clinically complete response' to chemoradiotherapy in oropharyngeal squamous cell carcinoma.
    Miah MS; Spielmann P; White SJ; Kennedy C; Kernohan N; Mountain RE; Cassasola R; Mahendran S
    J Laryngol Otol; 2015 Aug; 129(8):801-6. PubMed ID: 26087671
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Response evaluation of the neck in oropharyngeal cancer: Value of magnetic resonance imaging and influence of p16 in selecting patients for post-radiotherapy neck dissection.
    Lilja-Fischer JK; Jensen K; Eskildsen HW; Fink-Jensen V; Nielsen VE
    Acta Oncol; 2015; 54(9):1599-606. PubMed ID: 26198649
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Positron emission tomography/computed tomography after primary transoral robotic surgery for oropharyngeal squamous cell carcinoma.
    Hobelmann K; Luginbuhl A; Bar-Ad V; Keane W; Curry J; Cognetti D
    Laryngoscope; 2017 Sep; 127(9):2050-2056. PubMed ID: 28272799
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Intraindividual homogeneity of
    Sharma SJ; Wittekindt C; Knuth J; Steiner D; Wuerdemann N; Laur M; Kroll T; Wagner S; Klussmann JP
    Oral Oncol; 2017 Oct; 73():166-171. PubMed ID: 28939071
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Response assessment by combined PET-CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapy.
    Passero VA; Branstetter BF; Shuai Y; Heron DE; Gibson MK; Lai SY; Kim SW; Grandis JR; Ferris RL; Johnson JT; Argiris A
    Ann Oncol; 2010 Nov; 21(11):2278-2283. PubMed ID: 20430907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.